Article Versions Notes

Vasudevan S, Adejumobi IA, Alkhatib H, Roy Chowdhury S, Stefansky S, Rubinstein AM, Kravchenko-Balasha N. Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures. Cancers. 2021; 13(19):5009. https://doi.org/10.3390/cancers13195009

Vasudevan, Swetha, Ibukun A. Adejumobi, Heba Alkhatib, Sangita Roy Chowdhury, Shira Stefansky, Ariel M. Rubinstein, and Nataly Kravchenko-Balasha. 2021. "Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures" Cancers 13, no. 19: 5009. https://doi.org/10.3390/cancers13195009

Vasudevan, S., Adejumobi, I. A., Alkhatib, H., Roy Chowdhury, S., Stefansky, S., Rubinstein, A. M., & Kravchenko-Balasha, N. (2021). Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures. Cancers, 13(19), 5009. https://doi.org/10.3390/cancers13195009